Press releases and news

NEWS: Uppsala October 15, 2021. Senzime is proud to announce that the TetraGraph system received great focus during the American Society of Anesthesiology’s Annual meeting in San Diego October 8-12, as presented in the highlights below. A study...
Press release: Uppsala 4th of October 2021. At today’s Capital Market Day, Senzime provides a business update regarding ongoing businesses, evaluations, and key figures. Senzime markets CE and FDA approved systems and cloud-based software to digitally...
NEWS: Uppsala September 17, 2021. In the October 2021 edition of Anesthesiology, the Official Journal of the American Society of Anesthesiology, a comparative study of the Senzime TetraGraph EMG monitor and the previous gold-standard TOF-Watch AMG monitor...
NEWS: Uppsala September 13 2021. Recently published studies with an EMG monitor shows that the purchase can result in a robust cost benefit despite the expense associated with the technology, by reducing the risk of postoperative residual neuromuscular...
News: Uppsala, on 17 June 2021. Senzimes distributor comments on the field development following the new guidelines. In recent communications information on the new launch of the AAGBI guidelines were referenced. These guidelines state that in the UK...
News: Uppsala, on 22 May 2021. Senzime today announces that the Association of Anaesthetists in the UK and Ireland has issued new standards for neuromuscular monitoring stating that Quantitative neuromuscular monitoring is essential and should be available...
To take advantage of the opportunities the need for adequate anesthesia monitoring entails, Senzime is now expanding its commercial capacity in the US market through further recruitment of its own sales staff and by entering into distribution agreement...
As stated in the article, “Comparison of the TetraGraph and the TOFscan for monitoring recovery from neuromuscular blockade in the Post Anesthesia Care Unit”[1], the lead author, Dr. J. Ross Renew reports that the number of patients arriving...
There are more than 3,000 hospitals in South Korea and more than 700 000 operations are performed annually where anesthesia and muscle relaxants are used. “This is a huge leap for patient safety and an acknowledgement of the need to monitor patients...
The company has made the decision as a step in its continued expansion and in line with its commercial strategy. The company is in a strong growth and expansion phase with its own sales force in both the US and Germany, combined with having licensors...